MGTX - BestGrowthStocks.Com: MeiraGTx Holdings plc Actively Pursuing Strategic Partnerships and Asset Interest Potential Transactions
(NewsDirect)
Best Growth Stocks, aleading independent research and corporate access firm focused onfinding and reporting on the best growth stocks utilizing exclusiveai-assisted research recently issued a comprehensive analysis onMeiraGTx Holdings plc a vertically integrated, clinical stage genetherapy company.
In a Recent Press Release, MeiraGTx Holdings plc (NASDAQ: MGTX)announced a $30 million strategic investment from Sanofi. Thisinvestment involves the purchase of 4.0 million ordinary shares ofMeiraGTx at a price of $7.50 per share.
Best Growth Stock's full report breaksthrough the noise and offers an extensive comprehensive analysis ofMeiraGTx potential near-term catalysts, this recent news event, growthstrategy, and more.
Access this full Analysis: https://bestgrowthstocks.com/access-mgtx-analysis/
(copy and paste to browser may berequired)
AboutMeiraGTx
MeiraGTx (Nasdaq: MGTX) is a vertically integrated,clinical-stage gene therapy company with six programs in clinicaldevelopment and a broad pipeline of preclinical and research programs.MeiraGTx has core capabilities in viral vector design and optimizationand gene therapy manufacturing, and a transformative gene regulationplatform technology that allows precise, dose responsive control ofgene expression by oral small molecules with dynamic range that canexceed 5000-fold. Led by an experienced management team, MeiraGTx hastaken a portfolio approach by licensing, acquiring, and developingtechnologies that give depth across both product candidates andindications. MeiraGTx’s initial focus is on three distinct areas ofunmet medical need: ocular diseases, including both inherited retinaldiseases as well as large degenerative ocular diseases,neurodegenerative diseases and severe forms of xerostomia. Thoughinitially focusing on the eye, central nervous system, and salivarygland, MeiraGTx plans to expand its focus to develop additional genetherapy treatments for patients suffering from a range of seriousdiseases.
For moreinformation, please visit https://meiragtx.com/
About Best GrowthStocks
BestGrowth Stocks is a leading independent equity research and corporateaccess firm focused on finding and reporting on the best growth stocksutilizing our exclusive ai-assisted research. BGS is also a financialnews provider, focused on giving investors direct access to CEOs ofpromising, publicly-traded companies, and market experts. Our CEOinterviews aim to answer the questions that rest on the minds ofcurrent and future shareholders. This is not to be construed asfinancial advice. Please consult with a licensed financial advisorbefore making any investment decisions.
SOURCE: BestGrowthStocks.Com
ContactDetails
Best Growth Stocks
SteveMacalbry
Copyright (c) 2023 TheNewswire - All rights reserved.